-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Sonoma Pharmaceuticals, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q2 2010 to Q2 2024.
- Sonoma Pharmaceuticals, Inc. Depreciation, Depletion and Amortization for the quarter ending June 30, 2024 was $39K, a 13.3% decline year-over-year.
- Sonoma Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2023 was $176K, a 40.8% increase from 2022.
- Sonoma Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2022 was $125K, a 32.8% decline from 2021.
- Sonoma Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2021 was $186K, a 18.1% decline from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)